Octyl 3-(3,5-di-tert-butyl-4-hydroxyphenyl)propanoate, 95+%, 25g

2,3,4,5-Tetrahydro-1H-benzo[b]azepine, 97.0%, 1g

2-(3-Bromonaphthalen-2-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95%, 250mg

1-Methoxy-4-((prop-2-yn-1-yloxy)methyl)benzene, 97%, 250mg

N-[(11bS)-2,6-Bis[3,5-bis(trifluoromethyl)phenyl]-8,9,10,11,12,13,14,15-octahydro-4-oxidodinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-yl]-1,1,1-trifluoromethanesulfonamide, 98%, 100mg

Zernike Phasenkontrast-Set PLPH 10/20/40/100 Hellfeld- und Dunkelfeldposition

calcium (2S)-2-{[4-({[(6S)-2-amino-5-formyl-4-oxo-3,4,5,6,7,8-hexahydropteridin-6-yl]methyl}amino)phenyl]formamido}pentanedioate, 99.52%, 500mg

2-(3,4-Dihydroxyphenyl)-7-hydroxy-4H-chromen-4-one, 95.0%, 50mg

4-BROMO-1-METHYL-3-NITRO-1H-PYRAZOLE, 95.0%, 250mg

Methyl 2-amino-3-(4-iodophenyl)propanoate, 98%, 250mg

2,5-Dihydroxy-2,5-dimethyl-1,4-dithiane, 97.0%, 25g

3-Fluoro-2-methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, 95.0%, 250mg

TETRAETHYLAMMONIUM PERCHLORATE, 95%, 1g